On Thursday, shares in Laval, Canada-based Valeant Pharmaceuticals International Inc. ended the session 1.96% higher at $15.63 with a total volume of 15.72 million shares traded. Valeant Pharma's shares have advanced 6.47% in the past one month. The stock is trading 3.91% below its 50-day moving average and 34.69% below its 200-day moving average. Moreover, shares of the Company, which develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide, have a Relative Strength Index (RSI) of 52.01.
On January 04th, 2017, research firm Piper Jaffray reiterated its 'Underweight' rating on the Company's stock with a decrease of the target price from $16 a share to $11 a share. Sign up and read the free research report on VRX at:
On Thursday, shares in Dublin, Ireland headquartered Alkermes PLC recorded a trading volume of 816,213 shares. The stock ended the day 0.09% higher at $54.65. Alkermes' stock has gained 25.20% in the last three months. The Company is trading above its 200-day moving average by 14.74%. Furthermore, shares of Alkermes, which researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide, have an RSI of 41.43. The complimentary research report on ALKS can be downloaded at:
Universal Health Services
King of Prussia, Pennsylvania headquartered Universal Health Services Inc.'s stock finished Thursday's session 0.24% higher at $112.40 with a total volume of 665,961 shares traded. Over the last one month and the previous one year, Universal Health Services' shares have advanced 0.38% and 3.36%, respectively. The Company's shares are trading below its 50-day and 200-day moving averages by 2.82% and 10.05%, respectively. Shares of Universal Health Services, which through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers, are trading at a PE ratio of 15.85. The stock has an RSI of 55.10.
On January 04th, 2017, research firm Piper Jaffray initiated a 'Neutral' rating on the Company's stock. Register for free on Stock-Callers.com and access the latest report on UHS at:
Brentwood, Tennessee-based LifePoint Health Inc.'s stock edged 0.85% higher, to close the day at $59.15. The stock recorded a trading volume of 381,527 shares. LifePoint Health's shares have advanced 3.72% in the last one month. The Company's shares are trading 3.55% above its 50-day moving average. Shares of the Company, which through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the US, are trading at a PE ratio of 20.06. Additionally, the stock has an RSI of 60.29.
On January 04th, 2017, research firm Piper Jaffray initiated a 'Neutral' rating on the Company's stock. Get free access to your research report on LPNT at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA